Abstract
We exposed male and female rats of SHR (Spontaneously Hypertensive Rats) and SLA16 (SHR.LEW-Anxrr16) strains, in a non-drugged state, for five consecutive days to the Triple Test (experiment 1); or after repeated treatment with midazolam (MDZ), for four consecutive days. The fifth day was performed without treatment (experiment 2). The first experiment showed that males did not avoid and females increased the exploration of the open arms over the days. In experiment 2, SLA16 from both sexes approached more the open arms than SHR rats. The MDZ anxiolytic-like effect was sustained in both strains and sexes over the days. On the fifth day, SLA16 still approached more the open arms than SHR rats. Data suggest an absence of repeated-trial tolerance to MDZ anxiolytic-like effects. Testing the SHR and SLA16 strains, especially females, could be necessary for the future search for the genes and molecular pathways underlying anxiety/emotionality.
Similar content being viewed by others
References
Adamec R, Head D, Blundell J, Burton P, Berton O (2006) Lasting anxiogenic effects of feline predator stress in mice: sex differences in vulnerability to stress and predicting severity of anxiogenic response from the stress experience. Physiol Behav 2:12–29
Albrechet-Souza L, Borelli KG, Brandao ML (2008) Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze. J Neurosci Methods 169:109–118
Andreatini R, Vital M, Santos GL (2003) The reinstatement of conflict reverses the one-trial tolerance to diazepam on elevated plus maze. Eur Neuropsychopharmacol 13(Suppl. 4):S378–S379
Anselmi M, Correa FJ, Santos JR, Silva AF, Cunha JA, Leão AH, Campêlo CL, Ribeiro AM, Silva RH, Izídio GS (2016) Genetic evidence for chromosome 4 loci influencing learning and memory. Neurobiol Learn Mem 131:182–191
Becker JB, Prendergast BJ, Liang JW (2016) Female rats are not more variable than male rats: a meta-analysis of neuroscience studies. Biol Sex Differ 26:7–34
Beery AK, Zucker I (2011) Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev 35:565–572
Bertoglio LJ, Carobrez AP (2002a) Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus maze. Pharmacol Biochem Behav 72:449–455
Bertoglio LJ, Carobrez AP (2002b) Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze. Pharmacol Biochem Behav 73(4):963–969
Bertoglio LJ, Carobrez AP (2003) Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze Trial 2 in rats. Psychopharmacology 170:335–342
Bertoglio LJ, Carobrez AP (2004) Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Behav Pharmacol 15(1):45–54
Bertoglio LJ, Joca SR, Guimaraes FS (2006) Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav Brain Res 175:183–188
Carobrez AP, Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29:1193–1205
Carvalho MC, Moreira CM, Zanoveli JM, Brandão ML (2012) Central, but not basolateral, amygdala involvement in the anxiolytic-like effects of midazolam in rats in the elevated plus maze. J Psychopharmacol 26(4):543–554
Clayton JA, Collins FS (2014) Policy: NIH to balance sex in cell and animal studies. Nature 509:282–283
Cruz-Morales SE, Santos NR, Brandão ML (2002) One trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacol Biochem Behavior 72:973–978
Dal-Cól ML, Pereira LO, Rosa VP, Calixto AV, Carobrez AP, Faria MS (2003) Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1. Pharmacol Biochem Behav 74(2):395–400
Davids E, Zhang K, Tarazi FI, Baldessarini RJ (2003) Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev 2003 42(1):1–21
de Araújo Godinho MA, Meneghini L, Lucinda AM, Borges FR, Sakae DY, Marino Neto J, Paschoalini MA, De Lima TC, Faria MS (2007) An approach to evaluate the ability of rats to discriminate different levels of illumination in the plus maze test: effects of scopolamine. Behav Brain Res 4 180(1):86–94
De Medeiros GF, Pereira E, Granzotto N, Ramos A (2013) Low-anxiety rat phenotypes can be further reduced through genetic intervention. PLoS ONE 8(12):e83666
De Medeiros GF, Corrêa FJ, Corvino ME, Izídio GS, Ramos A (2014) The long way from complex phenotypes to genes: the story of rat chromosome 4 and its behavioral effects. World J Neurosci 4:203–215
Díaz-Véliz G, Butrón S, Benavides MS, Dussaubat N, Mora S (2000) Gender, estrous cycle, ovariectomy, and ovarian hormones influence the effects of diazepam on avoidance conditioning in rats. Pharmacol Biochem Behav 66(4):887–892
File SE (1990) One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology 100:281–282
File SE, Zangrossi H (1993) “One-trial tolerance” to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology 110:240–244
File SE, Zangrossi H Jr, Viana M, Graeff FG (1993) Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology 111(4):491–494
File SE, Gonzalez LE, Gallant R (1998) Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology 19:397–405
File SE, Gonzalez LE, Gallant R (1999) Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology 21:312–320
Fraser LM, Brown RE, Hussin A, Fontana M, Whittaker A, O’Leary TP, Lederle L, Holmes A, Ramos A (2010) Measuring anxiety- and locomotion related behaviours in mice: a new way of using old models. Psychopharmacology 211:99–112
Frussa-Filho R, Barbosa-Junior H, Silva RH, Da Cunha C, Mello CF (1999) Naltrexone potentiates the anxiolytic effects of chlordiazepoxide in rats exposed to novel environments. Psychopharmacology (Berl) 147:168–173
Gonzalez LE, File SE (1997) A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J Neurosci 17:1505–1511
Handley SL, Mcblane JW (1993) An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J Pharmacol Toxicol Methods 29:129–138
Hussin AT, Fraser LM, Ramos A, Brown RE (2012) The effect of chlordiazepoxide on measures of activity and anxiety in Swiss–Webster mice in the triple test. Neuropharmacology 63:883–889
Izídio GS, Spricigo LJR, Ramos A (2005) Genetic differences in the elevated plus-maze persist after first exposure of inbred rats to the test apparatus. Behav Process 68:129–134
Izídio GS, Oliveira LC, Oliveira LFG, Pereira E, Wehrmeister TD, Ramos A (2011) The influence of sex and estrous cycle on QTL for emotionality and ethanol consumption. Mamm Genome 22(5–6):329–340
Johnston AL, File SE (1991) Sex differences in animal tests of anxiety. Physiol Behav 49(2):245–250
Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185
Lovick TA (2008) GABA in the female brain-oestrous cycle-related changes in GABAergic function in the periaqueductal grey matter. Pharmacol Biochem Behav 90(1):43–50
Maguire J, Mody I (2009) Steroid hormone fluctuations and GABAAR plasticity. Psychoneuroendocrinology 34(1):S84–S90
Mccullough LD, de Vries GJ, Miller VM, Becker JB, Sandberg K, Mccarthy MM (2014) NIH initiative to balance sex of animals in preclinical studies. Biol Sex Differ 5:15
Pellow S, Chopin P, File SE, Briley M (1985) Validation of open-closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167
Pereira JK, Vieira RJ, Konishi CT, Ribeiro RA, Frussa-Filho R (1999) The phenomenon of “one-trial tolerance” to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Sci 65(10):101–107
Pértile R, Corvino ME, Marchette RCN, Pavesi E, Cavalli J, Ramos A, Izídio GS (2017) The quinpirole hypolocomotive effects are strain and route of administration dependent in SHR and SLA16 isogenic rats. Behav Genet 47(5):552–563
Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3–33
Ramos A, Berton O, Mormede P, Chaouloff F (1997) A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res (85): 57–69
Ramos A, Moisan MP, Chaouloff F, Mormède C, Mormède P (1999) Identification of female-specific QTLs affecting an emotionality-related behavior in rats. Mol Psychiatry (4):453–462
Ramos A, Pereira E, Martins GC, Wehrmeister TD, Izidio GS (2008) Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Behav Brain Res 193(2):277–288
Rodgers RJ, Shepherd JK (1993) Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology 113(2):237–242
Rodgers RJ, Lee C, Sheperd JK (1992) Effects of diazepam on behavioural an antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology 106:102–110
Roy V, Chapillon P, Jeljeli M, Caston J, Belzung C (2009) Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest. Psychopharmacology 203(1):131–141
Sagvolden T (2000) Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24:31–39
Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M (2005) Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1239–1247
Schneider P, Ho YJ, Spanagel R, Pawlak CR (2011) A novel elevated plus-maze procedure to avoid the one-trial tolerance problem. Front Behav Neurosci 5:43
Stern CAJ, Carobrez AP, Bertoglio LJ (2008) Aversive learning as a mechanism for lack of repeated anxiolytic- like effect in the elevated plus-maze. Pharmacol Biochem Behav 90:545–550
Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463–469
Tropp J, Markus EJ (2001) Sex differences in the dynamics of cue utilization and exploratory behavior. Behav Brain Res 119(2):143–154
Vendruscolo LF, Terenina-Rigaldie E, Raba F, Ramos A, Takahashi RN, Morméde P (2006) Evidence for a female-specific effect of a chromosome 4 locus on anxiety-related behaviors and ethanol drinking in rats. Genes Brain Behav 5(6):441–450
Voikar V, Koks S, Vasar E, Rauvala H (2001) Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 72(1–2):271–281
Wehrmeister TD, Izídio GS, Pereira E, Izídio G, Ramos A (2010) Absence of repeated-trial tolerance to the anxiolytic-like effects of chlordiazepoxide in the rat triple test. Pharmacol Biochem Behav 97(2):301–309
Acknowledgements
F. J. Correa and R. C. N. Marchette were recipients of fellowships from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). L. R. Acuña; N. GranzottoF. G. Mazur and E. Corvino were recipients of fellowships from Coordenadoria de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). The authors also thank R. A. N. Pértile and T. M. Alves for their technical assistance.
Funding
This work was supported by Edital MCTI/CNPq 14/2013.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Lucía Raily Acuña, Renata Cristina Nunes Marchette, Natalli Granzotto, Paula Gomes Dias, Maria Elisa Corvino, Fernando Gabriel Mazur, Fernanda Junques Corrêa and Geison Souza Izídio declare that they have no conflict of interest.
Ethical approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were by following the ethical standards of the institution or practice at which the studies were conducted and respected the guidelines of the local committee for Animal Care in Research (CEUA/UFSC) with the valid permission PP00903.
Additional information
Edited by Stephen Maxson.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Acuña, L.R., Marchette, R.C.N., Granzotto, N. et al. Effects of Repeated Treatment with Midazolam in SHR and SLA16 Rat Strains in the Triple Test. Behav Genet 48, 440–450 (2018). https://doi.org/10.1007/s10519-018-9922-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10519-018-9922-2